Amicogen, Inc.
092040.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.12B
Close$
Share Statistics
| Market cap | $56.12 Billion |
|---|---|
| Enterprise Value | $108.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-540.29 |
| Beta | 0.18 |
| Outstanding Shares | 70,453,000 |
Return
| Return on Equity | -16.35% |
|---|---|
| Return on Assets | -9.78% |
| Return on Invested Capital | -13.07% |
Valuation & Multiples
| P/E Ratio | -3.18 |
|---|---|
| PEG | -1.29 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 0.59 |
| Enterprise Value to Revenue | 2.32 |
| Enterprise Value to EBIT | -5.31 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
December 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Amicogen, Inc.
228 employees
CEO: Piao Zhe Amicogen, Inc. is an industrial biotechnology firm established in 2000, with its headquarters located in Jinju-si, South Korea, conducting business both domestically and globally. The company engineers and supplies a diverse range of spe...